Mitochondrial DNA depletion by ethidium bromide decreases neuronal mitochondrial creatine kinase: Implications for striatal energy metabolism
Open Access
- 29 December 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (12) , e0190456
Abstract
Mitochondrial DNA (mtDNA), the discrete genome which encodes subunits of the mitochondrial respiratory chain, is present at highly variable copy numbers across cell types. Though severe mtDNA depletion dramatically reduces mitochondrial function, the impact of tissue-specific mtDNA reduction remains debated. Previously, our lab identified reduced mtDNA quantity in the putamen of Parkinson’s Disease (PD) patients who had developed L-DOPA Induced Dyskinesia (LID), compared to PD patients who had not developed LID and healthy subjects. Here, we present the consequences of mtDNA depletion by ethidium bromide (EtBr) treatment on the bioenergetic function of primary cultured neurons, astrocytes and neuron-enriched cocultures from rat striatum. We report that EtBr inhibition of mtDNA replication and transcription consistently reduces mitochondrial oxygen consumption, and that neurons are significantly more sensitive to EtBr than astrocytes. EtBr also increases glycolytic activity in astrocytes, whereas in neurons it reduces the expression of mitochondrial creatine kinase mRNA and levels of phosphocreatine. Further, we show that mitochondrial creatine kinase mRNA is similarly downregulated in dyskinetic PD patients, compared to both non-dyskinetic PD patients and healthy subjects. Our data support a hypothesis that reduced striatal mtDNA contributes to energetic dysregulation in the dyskinetic striatum by destabilizing the energy buffering system of the phosphocreatine/creatine shuttle.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS048235)
- National Science Foundation (0922862)
- National Institutes of Health (S10 RR025677)
- National Institutes of Health (1S10OD018015)
- National Institutes of Health (HHSN-271-2013-00030C)
This publication has 97 references indexed in Scilit:
- Mitochondrial geneticsBritish Medical Bulletin, 2013
- The Glutamate–Glutamine (GABA) Cycle: Importance of Late Postnatal Development and Potential Reciprocal Interactions between Biosynthesis and DegradationFrontiers in Endocrinology, 2013
- Human mitochondrial DNA: roles of inherited and somatic mutationsNature Reviews Genetics, 2012
- A mitochondrial etiology of Alzheimer and Parkinson diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- The creatine kinase system and pleiotropic effects of creatineAmino Acids, 2011
- Mitochondrial dysfunction and pathology in bipolar disorder and schizophreniaInternational Journal of Developmental Neuroscience, 2010
- Mitochondrial abnormalities in the putamen in Parkinson’s disease dyskinesiaActa Neuropathologica, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitroJournal of Neuroscience Methods, 2008
- Mitochondrial DNA mutations in human diseaseNature Reviews Genetics, 2005